COLLEGIUM PHARMACEUTICAL, INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Collegium Pharmaceutical, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2014 to Q3 2024.
  • Collegium Pharmaceutical, Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 40.2M shares, a 4.51% decline year-over-year.
  • Collegium Pharmaceutical, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 41.8M shares, a 23.5% increase from 2022.
  • Collegium Pharmaceutical, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 33.8M shares, a 17.6% decline from 2021.
  • Collegium Pharmaceutical, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 41M shares, a 16.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 40.2M -1.9M -4.51% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 40.4M -2.47M -5.76% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 41.4M +7.12M +20.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 41.3M +7.7M +22.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 42.1M +7.49M +21.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 42.8M +8.85M +26% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 34.3M +645K +1.92% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 33.6M -541K -1.59% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 34.6M -1.69M -4.66% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-22
Q2 2022 34M -7.29M -17.6% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-22
Q1 2022 33.7M -7.49M -18.2% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-22
Q4 2021 34.1M -1.29M -3.65% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 36.3M +1.19M +3.4% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 41.3M +6.19M +17.7% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 41.2M +6.09M +17.4% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 35.4M +1.96M +5.87% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 35.1M +1.59M +4.74% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 35.1M +1.69M +5.07% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 35.1M +1.74M +5.21% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 33.5M -316K -0.94% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 33.5M +470K +1.42% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 33.4M +430K +1.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 33.3M +428K +1.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 33.8M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 33M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 33M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 32.9M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q1 2016 23.1M +15.6M +206% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-11
Q4 2015 20.6M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 20.5M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 11.8M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 7.55M +6.64M +728% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q1 2014 913K Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-07-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.